Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of Cartilage Defect Repair

NCT06823089 is registered in ClinicalTrials.gov with Cytex Therapeutics, Inc. as lead sponsor.

NCT NCT06823089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of Cartilage Defect Repair
Lead sponsor
Cytex Therapeutics, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 6, 2025
Completion date
October 31, 2031
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoroacetabular impingement, hip dysplasia, legg-calvé-perthes disease, osteoarthritis, hip, osteochondral lesion, osteonecrosis